| 摘要 |
<p>There is described disodium cromoglycate containing less than 5% by weight of water for use in a pharmaceutical composition comprising finely divided disodium cromoglycate, and a liquified propellent, the composition containing less than 5% by weight of water. The composition is indicated for use in the treatment of allergic conditions such as asthma and rhinitis.</p> |
